[Hearing evaluation of thalassemic patients with desferrioxamine therapy in Qazvin thalassemia center and Tehran pediatrics' medical center]
Audiology. 2003; (18-19): 31-35
en Persa
| IMEMR
| ID: emr-205726
ABSTRACT
Objective:
The purpose of study was identify hearing loss in thalassemic patients with history of Desferrioxamine [DFO] therapy. This study was carried out in a cross-sectional descriptive survey on 195 thalassemic patients [3-30 years old] in Gazvin Thalassemia center and Tehran pediatrics and apos medical center
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Idioma:
Persa
Revista:
Audiology
Año:
2003
Similares
MEDLINE
...
LILACS
LIS